Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022

Tinea, a dermatophyte fungal infection, is a common outpatient complaint that is easily misdiagnosed by visual inspection. Antifungal-drug-resistant tinea is an emerging global public health problem, with several cases reported in the United States. We analyzed data from a Spring 2022 web-based surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedict, Kaitlin, Wu, Karen, Gold, Jeremy A. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410453/
https://www.ncbi.nlm.nih.gov/pubmed/36012819
http://dx.doi.org/10.3390/jof8080831
_version_ 1784775097000656896
author Benedict, Kaitlin
Wu, Karen
Gold, Jeremy A. W.
author_facet Benedict, Kaitlin
Wu, Karen
Gold, Jeremy A. W.
author_sort Benedict, Kaitlin
collection PubMed
description Tinea, a dermatophyte fungal infection, is a common outpatient complaint that is easily misdiagnosed by visual inspection. Antifungal-drug-resistant tinea is an emerging global public health problem, with several cases reported in the United States. We analyzed data from a Spring 2022 web-based survey of healthcare provider attitudes and practices. Among 1500 healthcare providers, only 20.1% reported typically using diagnostic testing for tinea, and 19.5% reported clinical experience with drug-resistant tinea. Drug-resistant tinea may be more widespread than previously recognized. However, the low frequency of diagnostic testing indicates potential misunderstanding or misdiagnosis of drug-resistant tinea and missed opportunities to detect drug-resistant cases.
format Online
Article
Text
id pubmed-9410453
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94104532022-08-26 Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022 Benedict, Kaitlin Wu, Karen Gold, Jeremy A. W. J Fungi (Basel) Brief Report Tinea, a dermatophyte fungal infection, is a common outpatient complaint that is easily misdiagnosed by visual inspection. Antifungal-drug-resistant tinea is an emerging global public health problem, with several cases reported in the United States. We analyzed data from a Spring 2022 web-based survey of healthcare provider attitudes and practices. Among 1500 healthcare providers, only 20.1% reported typically using diagnostic testing for tinea, and 19.5% reported clinical experience with drug-resistant tinea. Drug-resistant tinea may be more widespread than previously recognized. However, the low frequency of diagnostic testing indicates potential misunderstanding or misdiagnosis of drug-resistant tinea and missed opportunities to detect drug-resistant cases. MDPI 2022-08-09 /pmc/articles/PMC9410453/ /pubmed/36012819 http://dx.doi.org/10.3390/jof8080831 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Benedict, Kaitlin
Wu, Karen
Gold, Jeremy A. W.
Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022
title Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022
title_full Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022
title_fullStr Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022
title_full_unstemmed Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022
title_short Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022
title_sort healthcare provider testing practices for tinea and familiarity with antifungal-drug-resistant tinea—united states, 2022
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410453/
https://www.ncbi.nlm.nih.gov/pubmed/36012819
http://dx.doi.org/10.3390/jof8080831
work_keys_str_mv AT benedictkaitlin healthcareprovidertestingpracticesfortineaandfamiliaritywithantifungaldrugresistanttineaunitedstates2022
AT wukaren healthcareprovidertestingpracticesfortineaandfamiliaritywithantifungaldrugresistanttineaunitedstates2022
AT goldjeremyaw healthcareprovidertestingpracticesfortineaandfamiliaritywithantifungaldrugresistanttineaunitedstates2022

Ejemplares similares